東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Molecular targeted therapy of lung c...

Takiguchi, Yuichi.

FindBook

Google Book

Amazon

博客來

Molecular targeted therapy of lung cancer

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Molecular targeted therapy of lung cancer/ edited by Yuichi Takiguchi.
其他作者:	Takiguchi, Yuichi.
出版者:	Singapore :Springer Singapore : : 2017.,
面頁冊數:	x, 327 p. :ill. (some col.), digital ;24 cm.
內容註:	Part I Diagnosis -- 1 Classification of adenocarcinoma of the lung - with a special reference to prognosis -- 2 Screening lung cancer with low dose CT combined with molecular markers -- 3 PET-CT, bio-imaging for predicting prognosis and response to chemotherapy in patients with lung cancer -- 4 Methods in molecular diagnosis -- 5 Accurate nodal staging and biomarker testing with endobronchial ultrasound-guided transbronchial needle aspiration -- 6 Next generation sequencing and bioinformatics -- 7 Companion Diagnostics -- Part II Treatment -- 8 Small cell lung cancer and molecular targeted therapy -- 9 Locally advanced non-small cell lung cancer and molecular targeted therapy -- 10 EGFR mutant -- 11 ALK mutant -- 12 Minor-driver mutant -- 13 Mechanism of resistance to targeted molecular therapy -- 14 Immunotherapy -- 15 Lung cancer complicated with interstitial lung diseases -- 16 Management of adverse effects by molecular targeted therapy and immunotherapy -- Part III Evaluation -- 17 Health related-quality of life in molecular targeted therapy -- 18 Gene signature -- Part IV Novel approach -- 19 Targeting epithelial-mesenchymal transition and cancer stem cell- 20 Targeting the Lung Cancer Microenvironment: Harnessing Host Responses.
Contained By:	Springer eBooks
標題:	Lungs - Cancer -
電子資源:	http://dx.doi.org/10.1007/978-981-10-2002-5
ISBN:	9789811020025

Molecular targeted therapy of lung cancer
Molecular targeted therapy of lung cancer[electronic resource] /edited by Yuichi Takiguchi. - Singapore :Springer Singapore :2017. - x, 327 p. :ill. (some col.), digital ;24 cm.

Part I Diagnosis -- 1 Classification of adenocarcinoma of the lung - with a special reference to prognosis -- 2 Screening lung cancer with low dose CT combined with molecular markers -- 3 PET-CT, bio-imaging for predicting prognosis and response to chemotherapy in patients with lung cancer -- 4 Methods in molecular diagnosis -- 5 Accurate nodal staging and biomarker testing with endobronchial ultrasound-guided transbronchial needle aspiration -- 6 Next generation sequencing and bioinformatics -- 7 Companion Diagnostics -- Part II Treatment -- 8 Small cell lung cancer and molecular targeted therapy -- 9 Locally advanced non-small cell lung cancer and molecular targeted therapy -- 10 EGFR mutant -- 11 ALK mutant -- 12 Minor-driver mutant -- 13 Mechanism of resistance to targeted molecular therapy -- 14 Immunotherapy -- 15 Lung cancer complicated with interstitial lung diseases -- 16 Management of adverse effects by molecular targeted therapy and immunotherapy -- Part III Evaluation -- 17 Health related-quality of life in molecular targeted therapy -- 18 Gene signature -- Part IV Novel approach -- 19 Targeting epithelial-mesenchymal transition and cancer stem cell- 20 Targeting the Lung Cancer Microenvironment: Harnessing Host Responses.

This book discusses the latest molecular targeted therapy of lung cancer including its evaluation and future directions. It clearly illustrates the initial dramatic effectiveness of molecular targeted therapy, recurrence of the disease, overcoming the wide variety of resistance mechanisms using new-generation molecular targeted agents and potential novel approaches. It also outlines the increasing necessity for new diagnostic technology and strategies for managing different adverse effects and novel methods for evaluating effectiveness and safety. Edited and authored by opinion leaders, Molecular Targeted Therapy of Lung Cancer provides a comprehensive overview of the disease and its treatments. It is a valuable resource for graduate students, post-doctoral fellows and faculty staff, as well as researchers involved in clinical and translational research on lung cancer, helping promote new ideas for further advances.

ISBN: 9789811020025

Standard No.: 10.1007/978-981-10-2002-5doiSubjects--Topical Terms:

2017391
Lungs
--Cancer

LC Class. No.: RC280.L8

Dewey Class. No.: 616.9942406

Molecular targeted therapy of lung cancer
LDR:03117nmm a2200313 a 4500 001 2089836
003 DE-He213
005 20170816143521.0
006 m d
007 cr nn 008maaau
008 171013s2017 si s 0 eng d
020 $a 9789811020025 $q (electronic bk.)
020 $a 9789811020001 $q (paper)
024 7 $a 10.1007/978-981-10-2002-5 $2 doi
035 $a 978-981-10-2002-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.L8
072 7 $a MJL $2 bicssc
072 7 $a MED079000 $2 bisacsh
082 0 4 $a 616.9942406 $2 23
090 $a RC280.L8 $b M718 2017
245 0 0 $a Molecular targeted therapy of lung cancer $h [electronic resource] / $c edited by Yuichi Takiguchi.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2017.
300 $a x, 327 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Part I Diagnosis -- 1 Classification of adenocarcinoma of the lung - with a special reference to prognosis -- 2 Screening lung cancer with low dose CT combined with molecular markers -- 3 PET-CT, bio-imaging for predicting prognosis and response to chemotherapy in patients with lung cancer -- 4 Methods in molecular diagnosis -- 5 Accurate nodal staging and biomarker testing with endobronchial ultrasound-guided transbronchial needle aspiration -- 6 Next generation sequencing and bioinformatics -- 7 Companion Diagnostics -- Part II Treatment -- 8 Small cell lung cancer and molecular targeted therapy -- 9 Locally advanced non-small cell lung cancer and molecular targeted therapy -- 10 EGFR mutant -- 11 ALK mutant -- 12 Minor-driver mutant -- 13 Mechanism of resistance to targeted molecular therapy -- 14 Immunotherapy -- 15 Lung cancer complicated with interstitial lung diseases -- 16 Management of adverse effects by molecular targeted therapy and immunotherapy -- Part III Evaluation -- 17 Health related-quality of life in molecular targeted therapy -- 18 Gene signature -- Part IV Novel approach -- 19 Targeting epithelial-mesenchymal transition and cancer stem cell- 20 Targeting the Lung Cancer Microenvironment: Harnessing Host Responses.
520 $a This book discusses the latest molecular targeted therapy of lung cancer including its evaluation and future directions. It clearly illustrates the initial dramatic effectiveness of molecular targeted therapy, recurrence of the disease, overcoming the wide variety of resistance mechanisms using new-generation molecular targeted agents and potential novel approaches. It also outlines the increasing necessity for new diagnostic technology and strategies for managing different adverse effects and novel methods for evaluating effectiveness and safety. Edited and authored by opinion leaders, Molecular Targeted Therapy of Lung Cancer provides a comprehensive overview of the disease and its treatments. It is a valuable resource for graduate students, post-doctoral fellows and faculty staff, as well as researchers involved in clinical and translational research on lung cancer, helping promote new ideas for further advances.
650 0 $a Lungs $x Cancer $x Treatment. $3 2017391
650 0 $a Lungs $x Cancer $x Molecular aspects. $3 895380
650 1 4 $a Medicine & Public Health. $3 890906
650 2 4 $a Pneumology/Respiratory System. $3 894348
650 2 4 $a Oncology. $3 751006
650 2 4 $a Molecular Medicine. $3 890952
700 1 $a Takiguchi, Yuichi. $3 3220819
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-981-10-2002-5
950 $a Medicine (Springer-11650)